Protein quality and digestibility of new high-lysine barley varieties in growing rats.

Plant Foods Hum Nutr

Department of Animal Physiology and Biochemistry, National Institute of Animal Science, Tjele, Denmark.

Published: September 1995

Four new high-lysine barley mutants, the variety 'Lysimax', with the high-lysine gene lys3a and the mutants mother variety 'Sultan' were grown in a field trial in 1993 at Risø, Denmark. Mutants 609, 1242, 1385 and 1405 yielded in the range of 89 to 98 percent and cv 'Lysimax' yielded 102 percent of cv 'Sultan' (100 percent). One-thousand kernel weights for the mutants were in the range of 87 to 97 percent and cv 'Lysimax' 83 percent of cv 'Sultan' (100 percent). Protein contents of the mutants were slightly higher, in the range of 13.2 to 13.6 percent, than of cv 'Sultan' (13.1 percent) and 'Lysimax' which had a protein content of 12.6 percent. Fat content was higher in 'Lysimax' and in the mutants except for mutant 1385 than in cv 'Sultan' while dietary fibre contents of the barleys were similar. The levels of beta-glucans and starch were usually lower in 'Lysimax' and in the mutants. The highest lysine levels: 4.6, 4.0 and 3.7 g/16 g N occurred in cv 'Lysimax' and mutants 609 and 1405 compared to 3.3, 3.3 and 3.2 for cv 'Sultan' and mutants 1242 and 1385, respectively. Mutants 609 and 1405 and cv 'Lysimax' also had higher levels of threonine, histidine and valine. The increased lysine contents resulted in large, at most 20 percent, increases in biological value; 88.8, 81.7 and 78.3 percent for cv 'Lysimax' and mutants 609 and 1405 compared to 74.2 percent for cv 'Sultan'. True protein digestibilities and energy digestibilities were slightly lower in 'Lysimax' than in 'Sultan', 5.3 and 4.3 percentage units, respectively. It is concluded that the development of high-lysine barley varieties is very beneficial for meeting the requirements of indispensable amino acids for humans and monogastric animals. In addition, nitrogen excretion into the environment is drastically reduced due to the higher biological values of the mutants.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF01088313DOI Listing

Publication Analysis

Top Keywords

mutants 609
16
percent 'lysimax'
16
percent 'sultan'
16
'lysimax' mutants
16
high-lysine barley
12
mutants
12
percent
12
609 1405
12
'lysimax'
10
barley varieties
8

Similar Publications

Background: CblC type methylmalonic aciduria (cblC disease) is the most common inborn error of vitamin B12 metabolism and due to mutations in the MMACHC gene. The earlier the diagnosis, the better the prognosis. Therefore, convenient and inexpensive detection method is needed.

View Article and Find Full Text PDF

Schizophrenia is a complex multifactorial disorder and increasing evidence suggests the involvement of immune dysregulations in its pathogenesis. We observed that IKZF1 and IKZF2, classic immune-related transcription factors (TFs), were both downregulated in patients' peripheral blood mononuclear cells (PBMCs) but not in their brain. We generated a new mutant mouse model with a reduction in Ikzf1 and Ikzf2 to study the impact of those changes.

View Article and Find Full Text PDF

Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.

Lancet Microbe

October 2024

National Institute for Medical Research, Dar es Salaam, Tanzania; Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Boston, MA, USA; Department of Biochemistry, Kampala International University in Tanzania, Dar es Salaam, Tanzania. Electronic address:

Article Synopsis
  • The study investigates the prevalence of the Arg561His mutation in the Plasmodium falciparum k13 gene and other antimalarial resistance markers in Tanzania, particularly near the border with Rwanda, due to rising concerns about resistance in the region.* -
  • A total of 6855 blood samples from malaria-positive individuals were collected and genotyped, revealing an overall mutation prevalence of 7.7% in the Kagera region, with higher rates closer to Rwanda.* -
  • Genetic analysis indicates a possible connection between some local P. falciparum strains and those previously recorded in Rwanda, suggesting a regional spread of resistance.*
View Article and Find Full Text PDF

Background: The role of tyrosine kinase inhibitors (TKIs) in early-stage and metastatic oncogene-driven non-small cell lung cancer (NSCLC) is established, but it remains unknown how best to integrate TKIs with concurrent chemoradiotherapy (cCRT) in locally advanced disease. The phase 2 ASCENT trial assessed the efficacy and safety of afatinib and cCRT with or without surgery in locally advanced epidermal growth factor receptor (EGFR)-mutant NSCLC.

Patients And Methods: Adults ≥18 years with histologically confirmed stage III (AJCC 7th edition) NSCLC with activating EGFR mutations were enrolled at Mass General and Dana-Farber/Brigham Cancer Centers, Boston, Massachusetts.

View Article and Find Full Text PDF

STAT3 is constitutively activated in many cancer types, including lung cancer, and can induce cancer cell proliferation and cancer stem cell (CSC) maintenance. STAT3 is activated by tyrosine kinases, such as JAK and SRC, but the mechanism by which STAT3 maintains its activated state in cancer cells remains unclear. Here, we show that PRMT5 directly methylates STAT3 and enhances its activated tyrosine phosphorylation in non-small cell lung cancer (NSCLC) cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!